Skip to main content
. 2017 Aug 31;102(11):1842–1849. doi: 10.3324/haematol.2017.174953

Table 1.

Patients’ characteristics at diagnosis for the sub-analysis of patients with chronic-phase-CML treated with a TKI.

graphic file with name 1021842.tab1.jpg